Skip to content
Lower risk Medical device recall · FDA · Published August 11, 2017

Randox Immunoassay Premium Controls Recall: Stability Issue

Randox recalls Immunoassay Premium Controls (3x4x5mL and 12x5mL packages) due to ACTH stability claims not meeting specifications. Affected lots include IA2633 (398703, 402366), IA2638 (1666EC), IA2639 (1486EC, 1516EC, 1626EC), and IA2640 (1517EC, 1668EC).

🇺🇸 FDA recall #Z-0969-2018Medical deviceRandox ›
Take action

Contact the company

Recalling firmRandox Laboratories515 Industrial Blvd · Kearneysville, WV 25430-2778
✎ GovInfoNow plain-language explainer

What happened, in plain English

Randox is recalling Immunoassay Premium Controls (3x4x5mL and 12x5mL packages) because the ACTH in these products does not meet the stability claims listed in the product instructions. This could lead to inaccurate test results if the controls are used after the stability period expires. Read more at govinfonow.com/recall/73145-randox-immunoassay-premium-controls-recall-stability-issue.

Source Summary by GovInfoNow · govinfonow.com/recall/73145-randox-immunoassay-premium-controls-recall-stability-issue · Updated September 18, 2026 · FDA enforcement record: FDA #Z-0969-2018

Cite this page

“Randox Immunoassay Premium Controls Recall: Stability Issue.” GovInfoNow, updated September 18, 2026. https://govinfonow.com/recall/73145-randox-immunoassay-premium-controls-recall-stability-issue. Based on FDA recall #Z-0969-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0969-2018%22&limit=1).

Why it’s dangerous

The ACTH in the Immunoassay Premium Controls does not maintain stability as claimed in the product instructions. This means the controls might not work properly after the specified stability period, potentially leading to inaccurate test results.

Who’s affected

Lab users who purchased Immunoassay Premium Controls with the specific catalog numbers and lots listed above are affected. Those using these controls for medical testing may be at risk of inaccurate results if the stability claim is not met.

How to tell if you have this one

Check the catalog number on the package, which includes IA2633 (Lots: 398703, 402366), IA2638 (Lot 1666EC), IA2639 (Lots: 1486EC, 1516EC, 1626EC), and IA2640 (Lots 1517EC, 1668EC).

  • Brand
    Randox
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Distribution US nationwide.
Recall numberProduct, codes & lotsQuantity
Z-0969-2018Immunoassay Premium Controls (3x4x5mL and 12x5mL packages); Catalog numbers: IA2633 (Lots: 398703, 402366) IA2638 (Lot 1666EC) IA2639 (Lots: 1486EC, 1516EC, 1626EC) IA2640 (Lots 1517EC, 1668EC)117 Kits
Z-0970-2018Immunoassay Premium Plus Controls (3x4x5mL and 12x5mL packages); Catalog numbers: IA3109 (Lots: 1476EC, 1573EC, 1619EC) IA3110 (Lots 1477EDC, 1599EDC, 1621EC, 1662EC) IA3111 (Lots: 1478EC, 1508EC, 1578EC, 1647EC) IA3112 (Lots: 359199, 377412, 373302, 382147, 382679, 395668, 416979)199 Kits
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot Numbers

    Look for the catalog numbers and lot numbers listed in the recall notice to confirm if your product is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distribution US nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 20 months after the firm started it.

1. Firm started the recall: Aug 11, 201712. FDA classified it Class III: Mar 12, 201823. Published in FDA’s Enforcement Report: Mar 21, 201834. FDA terminated the recall: Mar 29, 2019420172019
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0969-2018 (August 11, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0969-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on September 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA